Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial.
Tobias WollersheimLilian Jo EngelhardtJeanne PachullaRudolf MoergeliSusanne KochClaudia SpiesMichael HiesmayrSteffen Weber-CarstensPublished in: Annals of intensive care (2016)
The subcutaneous CGM system did not perform with satisfactory accuracy, feasibility, or nursing acceptance when evaluated in 20 medical-surgical ICU patients. Low point accuracy and prolonged data gaps significantly limited the potential clinical usefulness of the CGM trend data. Accurate continuous data display, with a MARD < 14 %, showed potential benefits in a subgroup of our patients. Trial registration NCT02296372; Ethic vote Charité EA2/095/14.
Keyphrases
- end stage renal disease
- clinical trial
- chronic kidney disease
- ejection fraction
- healthcare
- electronic health record
- peritoneal dialysis
- primary care
- mental health
- phase iii
- high resolution
- phase ii
- skeletal muscle
- machine learning
- blood pressure
- adipose tissue
- open label
- insulin resistance
- weight loss
- patient reported
- data analysis